Nature Medicine
This journal encompasses original research ranging from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative technologies aimed at improving human health.
Generating synthetic medical data improves clinical applications
The scarcity of high-quality medical imaging datasets can be addressed by generative AI.
We Need More Realistic Benchmarks for AI Models in Medicine
Large Language Models have shown impressive capabilities, but their medical knowledge has so far only been tested on medical licensing exams. We find that on more realistic tasks, such as clinical decision making, they lag behind medical experts, highlighting the need for more realistic benchmarks.
Omomyc is finally in the clinic. What a journey!
MYC is the most deregulated oncogene in human cancer, where it directs transcriptional programs that allow cancer cells to thrive and survive therapies. Despite being a most wanted target in cancer treatment, it has been long considered undruggable.
Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection – the Antibody Mediated Prevention (AMP) trials
A new biomarker appears to be an effective surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1. Broadly neutralizing antibodies (bnAbs) are defined by their ability to neutralize multiple genetically distinct viral strains.
Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium
Multiple non-endemic countries were recently hit by a monkeypox virus outbreak. While most cases present with lesions in the anogenital region, it is unclear whether asymptomatic or otherwise undiagnosed infections are fuelling this epidemic.
